Comparative effectiveness of switching to natalizumab or fingolimod after relapse on first-line relapsing-remitting multiple sclerosis therapy: propensity score matching analysis from the MSBase registry.


Spelman T., Harvrdova E. K. , Horakova D., Izquierdo G., Kalincik T., Lugaresi A., ...More

34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, Germany, 10 - 12 October 2018, vol.24, pp.25-26 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 24
  • City: Berlin
  • Country: Germany
  • Page Numbers: pp.25-26